Researchers seek to answer longstanding debate
Published on: 11 Feb 2019
Scanner will deliver clear images of the nervous system in exceptional detail
Scientists will see the human nervous system in microscopic detail thanks to the installation of Canada鈥檚 first 7-Tesla whole-body magnetic resonance imaging (MRI) scanner on Feb. 5.
Category:
Published on: 5 Feb 2019
Technique involves use of non-invasive digital infrared imaging
Published on: 31 Jan 2019
Reinhardt lab receives 5-year CIHR grant to investigate extracellular matrix-mediated regulation of microRNAs in health and disease. Congratulations!
Category:
Published on: 24 Jan 2019
缅北强奸 and MUHC research teams part of an international effort to uncover how chronic inflammation causes cancer
听
Published on: 23 Jan 2019
Ghrelin promotes conditioning to food-related odours
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty food smells, encouraging overeating and obesity. New research on the hormone ghrelin was published on Dec. 4, 2018, led by Dr. Alain Dagher鈥檚 lab at the Montreal Neurological Institute and Hospital of 缅北强奸.
Category:
Published on: 12 Dec 2018
Reducing stigma may address cognitive impairment in this population
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
Category:
Published on: 27 Nov 2018
Concerns raised about efficacy of off-label use of already approved drugs
A new paper published by 缅北强奸 researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments. That鈥檚 the opposite of what clinical trials are aimed at, namely preventing ineffective and costly treatments from being taken up by physicians and patients.
Published on: 26 Nov 2018
Source: MUHC Newsroom
Published on: 16 Nov 2018
- Regular cytology screening (pap or smear test) is still the most commonly used HPV screening method, and can prevent cancers up to age 75 years, although benefits decline with age
- For the newly introduced HPV DNA test, which offers a higher degree of accuracy, women aged 55 who have a negative test were predicted to be at low risk of cervical cancer听
Published on: 2 Nov 2018
Source: Cell Metabolism
New research suggests that higher-level brain functions have a major role in losing weight. In a study among 24 participants at a weight-loss clinic, those who achieved greatest success in terms of weight loss demonstrated more activity in the brain regions of the lateral prefrontal cortex associated with self-control. The results of the study were published in听Cell Metabolism听on October 18.
Published on: 18 Oct 2018
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous 鈥� they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
Category:
Published on: 15 Oct 2018
Researchers discover additional targets for existing drugs used to treat a specific melanoma
听
A set of targeted cancer drugs, known as BRAF and MEK inhibitors, have proven to be beneficial for some metastatic melanoma patients whose tumours include a specific mutation in the BRAF gene, known as V600E. A recent study conducted in the lab of Dr. Peter Siegel at 缅北强奸鈥檚 Goodman Cancer Research Centre suggests that these same drugs may prove beneficial for a broader range of cancer patients.
Published on: 4 Oct 2018
The Consortium for Industrial Research and Innovation in Medical Technologies, , and the Healthy Brains for Healthy Lives (HBHL) initiative of 缅北强奸 are pleased to announce a joint agreement that will harmonize the process of developing research and innovation projects related to medical technologies.
Category:
Published on: 3 Oct 2018
Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson鈥檚 disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
Category:
Published on: 1 Oct 2018
Pages
